Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma
This study demonstrates the clinical and biological significance of KPNA2 in ACC and suggests that KPNA2 could serve as a promising biomarker for predicting prognosis and immunotherapeutic responses in pediatric and adult ACC patients.
Authors
- Shanshan Mo (ORCID: https://orcid.org/0000-0002-0527-652X)
- Weide Zhong (ORCID: https://orcid.org/0000-0002-0430-2845)
- Chuanfan Zhong (ORCID: https://orcid.org/0000-0002-0824-1517)
- Xiaohui Ling (ORCID: https://orcid.org/0000-0002-1182-369X)
- Jianming Lü (ORCID: https://orcid.org/0000-0002-3794-641X)
- Junhong Deng
- Shumin Fang (ORCID: https://orcid.org/0000-0002-0715-7890)
- Yi‐Hao Chen (ORCID: https://orcid.org/0000-0002-9977-7180)
- Fengping Liu (ORCID: https://orcid.org/0000-0003-4346-5724)
- Yongcheng Shi
- Jia-Hong Chen (ORCID: https://orcid.org/0009-0005-6294-6189)
- Zhong Dong
Institutions
- Macau University of Science and Technology (MO)
- Guangzhou First People's Hospital (CN)
- Zhujiang Hospital (CN)
- Huizhou Central People's Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1080/07853890.2024.2397092
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- National Natural Science Foundation of China